Galectin Therapeutics Inc (GALT)
3.235
+0.10
(+3.03%)
USD |
NASDAQ |
May 17, 16:00
3.235
0.00 (0.00%)
After-Hours: 18:49
Galectin Therapeutics Max Drawdown (5Y): 88.76% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 88.76% |
March 31, 2024 | 88.76% |
February 29, 2024 | 88.76% |
January 31, 2024 | 88.76% |
December 31, 2023 | 88.76% |
November 30, 2023 | 88.76% |
October 31, 2023 | 88.76% |
September 30, 2023 | 88.76% |
August 31, 2023 | 88.76% |
July 31, 2023 | 88.76% |
June 30, 2023 | 88.76% |
May 31, 2023 | 88.76% |
April 30, 2023 | 88.76% |
March 31, 2023 | 88.76% |
February 28, 2023 | 88.76% |
January 31, 2023 | 88.76% |
December 31, 2022 | 88.76% |
November 30, 2022 | 87.55% |
October 31, 2022 | 87.01% |
September 30, 2022 | 91.58% |
August 31, 2022 | 91.58% |
July 31, 2022 | 91.58% |
June 30, 2022 | 91.58% |
May 31, 2022 | 91.58% |
April 30, 2022 | 91.58% |
Date | Value |
---|---|
March 31, 2022 | 91.58% |
February 28, 2022 | 91.58% |
January 31, 2022 | 91.58% |
December 31, 2021 | 91.58% |
November 30, 2021 | 94.48% |
October 31, 2021 | 94.81% |
September 30, 2021 | 95.25% |
August 31, 2021 | 97.21% |
July 31, 2021 | 97.21% |
June 30, 2021 | 97.21% |
May 31, 2021 | 97.21% |
April 30, 2021 | 97.21% |
March 31, 2021 | 97.21% |
February 28, 2021 | 97.21% |
January 31, 2021 | 97.21% |
December 31, 2020 | 97.21% |
November 30, 2020 | 97.21% |
October 31, 2020 | 97.21% |
September 30, 2020 | 97.21% |
August 31, 2020 | 97.21% |
July 31, 2020 | 97.21% |
June 30, 2020 | 97.21% |
May 31, 2020 | 97.21% |
April 30, 2020 | 97.21% |
March 31, 2020 | 97.21% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
87.01%
Minimum
Oct 2022
97.21%
Maximum
May 2019
93.43%
Average
94.64%
Median
Max Drawdown (5Y) Benchmarks
Madrigal Pharmaceuticals Inc | 82.20% |
Viking Therapeutics Inc | 89.26% |
89bio Inc | -- |
Terns Pharmaceuticals Inc | -- |
Enanta Pharmaceuticals Inc | 92.26% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -13.95 |
Beta (5Y) | 0.719 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 79.13% |
Historical Sharpe Ratio (5Y) | -0.075 |
Historical Sortino (5Y) | -0.2285 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.73% |